1 Report Overview 1.1 Study Scope 1.2 Market Analysis by Type 1.2.1 Global Breast Cancer Diagnostic Market Size Growth Rate by Type: 2020 VS 2026 1.2.2 Imaging 1.2.3 Biopsy 1.2.4 Others 1.3 Market by Application 1.3.1 Global Breast Cancer Diagnostic Market Share by Application: 2020 VS 2026 1.3.2 Hospitals 1.3.3 Clinics 1.3.4 Others 1.4 Study Objectives 1.5 Years Considered 2 Global Growth Trends 2.1 Global Breast Cancer Diagnostic Market Perspective (2015-2026) 2.2 Global Breast Cancer Diagnostic Growth Trends by Regions 2.2.1 Breast Cancer Diagnostic Market Size by Regions: 2015 VS 2020 VS 2026 2.2.2 Breast Cancer Diagnostic Historic Market Share by Regions (2015-2020) 2.2.3 Breast Cancer Diagnostic Forecasted Market Size by Regions (2021-2026) 2.3 Industry Trends and Growth Strategy 2.3.1 Market Trends 2.3.2 Market Drivers 2.3.3 Market Challenges 2.3.4 Market Restraints 3 Competition Landscape by Key Players 3.1 Global Top Breast Cancer Diagnostic Players by Market Size 3.1.1 Global Top Breast Cancer Diagnostic Players by Revenue (2015-2020) 3.1.2 Global Breast Cancer Diagnostic Revenue Market Share by Players (2015-2020) 3.2 Global Breast Cancer Diagnostic Market Share by Company Type (Tier 1, Tier 2 and Tier 3) 3.3 Players Covered: Ranking by Breast Cancer Diagnostic Revenue 3.4 Global Breast Cancer Diagnostic Market Concentration Ratio 3.4.1 Global Breast Cancer Diagnostic Market Concentration Ratio (CR5 and HHI) 3.4.2 Global Top 10 and Top 5 Companies by Breast Cancer Diagnostic Revenue in 2019 3.5 Key Players Breast Cancer Diagnostic Area Served 3.6 Key Players Breast Cancer Diagnostic Product Solution and Service 3.7 Date of Enter into Breast Cancer Diagnostic Market 3.8 Mergers & Acquisitions, Expansion Plans 4 Breast Cancer Diagnostic Breakdown Data by Type (2015-2026) 4.1 Global Breast Cancer Diagnostic Historic Market Size by Type (2015-2020) 4.2 Global Breast Cancer Diagnostic Forecasted Market Size by Type (2021-2026) 5 Breast Cancer Diagnostic Breakdown Data by Application (2015-2026) 5.1 Global Breast Cancer Diagnostic Historic Market Size by Application (2015-2020) 5.2 Global Breast Cancer Diagnostic Forecasted Market Size by Application (2021-2026) 6 North America 6.1 North America Breast Cancer Diagnostic Market Size (2015-2026) 6.2 North America Breast Cancer Diagnostic Market Size by Type (2015-2020) 6.3 North America Breast Cancer Diagnostic Market Size by Application (2015-2020) 6.4 North America Breast Cancer Diagnostic Market Size by Country (2015-2020) 6.4.1 United States 6.4.2 Canada 7 Europe 7.1 Europe Breast Cancer Diagnostic Market Size (2015-2026) 7.2 Europe Breast Cancer Diagnostic Market Size by Type (2015-2020) 7.3 Europe Breast Cancer Diagnostic Market Size by Application (2015-2020) 7.4 Europe Breast Cancer Diagnostic Market Size by Country (2015-2020) 7.4.1 Germany 7.4.2 France 7.4.3 U.K. 7.4.4 Italy 7.4.5 Russia 7.4.6 Nordic 7.4.7 Rest of Europe 8 China 8.1 China Breast Cancer Diagnostic Market Size (2015-2026) 8.2 China Breast Cancer Diagnostic Market Size by Type (2015-2020) 8.3 China Breast Cancer Diagnostic Market Size by Application (2015-2020) 8.4 China Breast Cancer Diagnostic Market Size by Region (2015-2020) 8.4.1 China 8.4.2 Japan 8.4.3 South Korea 8.4.4 Southeast Asia 8.4.5 India 8.4.6 Australia 8.4.7 Rest of Asia-Pacific 9 Japan 9.1 Japan Breast Cancer Diagnostic Market Size (2015-2026) 9.2 Japan Breast Cancer Diagnostic Market Size by Type (2015-2020) 9.3 Japan Breast Cancer Diagnostic Market Size by Application (2015-2020) 9.4 Japan Breast Cancer Diagnostic Market Size by Country (2015-2020) 9.4.1 Mexico 9.4.2 Brazil 10 Southeast Asia 10.1 Southeast Asia Breast Cancer Diagnostic Market Size (2015-2026) 10.2 Southeast Asia Breast Cancer Diagnostic Market Size by Type (2015-2020) 10.3 Southeast Asia Breast Cancer Diagnostic Market Size by Application (2015-2020) 10.4 Southeast Asia Breast Cancer Diagnostic Market Size by Country (2015-2020) 10.4.1 Turkey 10.4.2 Saudi Arabia 10.4.3 UAE 10.4.4 Rest of Middle East & Africa 11 Key Players Profiles 11.1 Danaher 11.1.1 Danaher Company Details 11.1.2 Danaher Business Overview 11.1.3 Danaher Breast Cancer Diagnostic Introduction 11.1.4 Danaher Revenue in Breast Cancer Diagnostic Business (2015-2020)) 11.1.5 Danaher Recent Development 11.2 Hologic 11.2.1 Hologic Company Details 11.2.2 Hologic Business Overview 11.2.3 Hologic Breast Cancer Diagnostic Introduction 11.2.4 Hologic Revenue in Breast Cancer Diagnostic Business (2015-2020) 11.2.5 Hologic Recent Development 11.3 Merit Medical 11.3.1 Merit Medical Company Details 11.3.2 Merit Medical Business Overview 11.3.3 Merit Medical Breast Cancer Diagnostic Introduction 11.3.4 Merit Medical Revenue in Breast Cancer Diagnostic Business (2015-2020) 11.3.5 Merit Medical Recent Development 11.4 BD 11.4.1 BD Company Details 11.4.2 BD Business Overview 11.4.3 BD Breast Cancer Diagnostic Introduction 11.4.4 BD Revenue in Breast Cancer Diagnostic Business (2015-2020) 11.4.5 BD Recent Development 11.5 Stryker 11.5.1 Stryker Company Details 11.5.2 Stryker Business Overview 11.5.3 Stryker Breast Cancer Diagnostic Introduction 11.5.4 Stryker Revenue in Breast Cancer Diagnostic Business (2015-2020) 11.5.5 Stryker Recent Development 11.6 Galini SRL 11.6.1 Galini SRL Company Details 11.6.2 Galini SRL Business Overview 11.6.3 Galini SRL Breast Cancer Diagnostic Introduction 11.6.4 Galini SRL Revenue in Breast Cancer Diagnostic Business (2015-2020) 11.6.5 Galini SRL Recent Development 11.7 Medtronic 11.7.1 Medtronic Company Details 11.7.2 Medtronic Business Overview 11.7.3 Medtronic Breast Cancer Diagnostic Introduction 11.7.4 Medtronic Revenue in Breast Cancer Diagnostic Business (2015-2020) 11.7.5 Medtronic Recent Development 12 Analyst's Viewpoints/Conclusions 13 Appendix 13.1 Research Methodology 13.1.1 Methodology/Research Approach 13.1.2 Data Source 13.2 Disclaimer 13.3 Author Details

List of Tables Table 1. Global Breast Cancer Diagnostic Market Size Growth Rate by Type (US$ Million): 2020 VS 2026 Table 3. Key Players of Imaging Table 4. Key Players of Biopsy Table 5. Key Players of Others Table 6. Global Breast Cancer Diagnostic Market Size Growth by Application (US$ Million): 2020 VS 2026 Table 7. Global Breast Cancer Diagnostic Market Size by Regions (US$ Million): 2020 VS 2026 Table 8. Global Breast Cancer Diagnostic Market Size by Regions (2015-2020) (US$ Million) Table 9. Global Breast Cancer Diagnostic Market Share by Regions (2015-2020) Table 10. Global Breast Cancer Diagnostic Forecasted Market Size by Regions (2021-2026) (US$ Million) Table 11. Global Breast Cancer Diagnostic Market Share by Regions (2021-2026) Table 12. Breast Cancer Diagnostic Market Market Trends Table 13. Breast Cancer Diagnostic Market Drivers Table 14. Breast Cancer Diagnostic Market Challenges Table 15. Breast Cancer Diagnostic Market Restraints Table 16. Global Breast Cancer Diagnostic Revenue by Players (2015-2020) (US$ Million) Table 17. Global Breast Cancer Diagnostic Market Share by Players (2015-2020) Table 18. Global Top Breast Cancer Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Diagnostic as of 2019) Table 19. Global Breast Cancer Diagnostic by Players Market Concentration Ratio (CR5 and HHI) Table 20. Key Players Headquarters and Area Served Table 21. Key Players Breast Cancer Diagnostic Product Solution and Service Table 22. Mergers & Acquisitions, Expansion Plans Table 23. Global Breast Cancer Diagnostic Market Size by Type (2015-2020) (US$ Million) Table 24. Global Breast Cancer Diagnostic Market Size Share by Type (2015-2020) Table 25. Global Breast Cancer Diagnostic Revenue Market Share by Type (2021-2026) Table 26. Global Breast Cancer Diagnostic Market Size Share by Application (2015-2020) Table 27. Global Breast Cancer Diagnostic Market Size by Application (2015-2020) (US$ Million) Table 28. Global Breast Cancer Diagnostic Market Size Share by Application (2021-2026) Table 29. North America Breast Cancer Diagnostic Market Size by Type (2015-2020) (US$ Million) Table 30. North America Breast Cancer Diagnostic Market Share by Type (2015-2020) Table 31. North America Breast Cancer Diagnostic Market Size by Application (2015-2020) (US$ Million) Table 32. North America Breast Cancer Diagnostic Market Share by Application (2015-2020) Table 33. North America Breast Cancer Diagnostic Market Size by Country (US$ Million) (2015-2020) Table 34. North America Breast Cancer Diagnostic Market Share by Country (2015-2020) Table 35. Europe Breast Cancer Diagnostic Market Size by Type (2015-2020) (US$ Million) Table 36. Europe Breast Cancer Diagnostic Market Share by Type (2015-2020) Table 37. Europe Breast Cancer Diagnostic Market Size by Application (2015-2020) (US$ Million) Table 38. Europe Breast Cancer Diagnostic Market Share by Application (2015-2020) Table 39. Europe Breast Cancer Diagnostic Market Size by Country (US$ Million) (2015-2020) Table 40. Europe Breast Cancer Diagnostic Market Share by Country (2015-2020) Table 41. China Breast Cancer Diagnostic Market Size by Type (2015-2020) (US$ Million) Table 42. China Breast Cancer Diagnostic Market Share by Type (2015-2020) Table 43. China Breast Cancer Diagnostic Market Size by Application (2015-2020) (US$ Million) Table 44. China Breast Cancer Diagnostic Market Share by Application (2015-2020) Table 45. China Breast Cancer Diagnostic Market Size by Region (US$ Million) (2015-2020) Table 46. China Breast Cancer Diagnostic Market Share by Region (2015-2020) Table 47. Japan Breast Cancer Diagnostic Market Size by Type (2015-2020) (US$ Million) Table 48. Japan Breast Cancer Diagnostic Market Share by Type (2015-2020) Table 49. Japan Breast Cancer Diagnostic Market Size by Application (2015-2020) (US$ Million) Table 50. Japan Breast Cancer Diagnostic Market Share by Application (2015-2020) Table 51. Japan Breast Cancer Diagnostic Market Size by Country (US$ Million) (2015-2020) Table 52. Japan Breast Cancer Diagnostic Market Share by Country (2015-2020) Table 53. Southeast Asia Breast Cancer Diagnostic Market Size by Type (2015-2020) (US$ Million) Table 54. Southeast Asia Breast Cancer Diagnostic Market Share by Type (2015-2020) Table 55. Southeast Asia Breast Cancer Diagnostic Market Size by Application (2015-2020) (US$ Million) Table 56. Southeast Asia Breast Cancer Diagnostic Market Share by Application (2015-2020) Table 57. Southeast Asia Breast Cancer Diagnostic Market Size by Country (US$ Million) (2015-2020) Table 58. Southeast Asia Breast Cancer Diagnostic Market Share by Country (2015-2020) Table 59. Danaher Company Details Table 60. Danaher Business Overview Table 61. Danaher Product Table 62. Danaher Revenue in Breast Cancer Diagnostic Business (2015-2020) (US$ Million) Table 63. Danaher Recent Development Table 64. Hologic Company Details Table 65. Hologic Business Overview Table 66. Hologic Product Table 67. Hologic Revenue in Breast Cancer Diagnostic Business (2015-2020) (US$ Million) Table 68. Hologic Recent Development Table 69. Merit Medical Company Details Table 70. Merit Medical Business Overview Table 71. Merit Medical Product Table 72. Merit Medical Revenue in Breast Cancer Diagnostic Business (2015-2020) (US$ Million) Table 73. Merit Medical Recent Development Table 74. BD Company Details Table 75. BD Business Overview Table 76. BD Product Table 77. BD Revenue in Breast Cancer Diagnostic Business (2015-2020) (US$ Million) Table 78. BD Recent Development Table 79. Stryker Company Details Table 80. Stryker Business Overview Table 81. Stryker Product Table 82. Stryker Revenue in Breast Cancer Diagnostic Business (2015-2020) (US$ Million) Table 83. Stryker Recent Development Table 84. Galini SRL Company Details Table 85. Galini SRL Business Overview Table 86. Galini SRL Product Table 87. Galini SRL Revenue in Breast Cancer Diagnostic Business (2015-2020) (US$ Million) Table 88. Galini SRL Recent Development Table 89. Medtronic Company Details Table 90. Medtronic Business Overview Table 91. Medtronic Product Table 92. Medtronic Revenue in Breast Cancer Diagnostic Business (2015-2020) (US$ Million) Table 93. Medtronic Recent Development Table 94. Research Programs/Design for This Report Table 95. Key Data Information from Secondary Sources Table 96. Key Data Information from Primary Sources List of Figures Figure 1. Global Breast Cancer Diagnostic Market Share by Type: 2020 VS 2026 Figure 2. Imaging Features Figure 3. Biopsy Features Figure 4. Others Features Figure 5. Global Breast Cancer Diagnostic Market Share by Application: 2020 VS 2026 Figure 6. Hospitals Case Studies Figure 7. Clinics Case Studies Figure 8. Others Case Studies Figure 9. Breast Cancer Diagnostic Report Years Considered Figure 10. Global Breast Cancer Diagnostic Market Size (US$ Million), YoY Growth 2015-2026 Figure 11. Global Breast Cancer Diagnostic Market Share by Regions: 2020 VS 2026 Figure 12. Global Breast Cancer Diagnostic Market Share by Regions (2021-2026) Figure 13. Global Breast Cancer Diagnostic Market Share by Players in 2019 Figure 14. Global Top Breast Cancer Diagnostic Players by Company Type (Tier 1, Tier 2 and Tier 3) (based on the Revenue in Breast Cancer Diagnostic as of 2019 Figure 15. The Top 10 and 5 Players Market Share by Breast Cancer Diagnostic Revenue in 2019 Figure 16. North America Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 17. United States Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 18. Canada Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 19. Europe Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 20. Germany Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 21. France Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 22. U.K. Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 23. Italy Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 24. Russia Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 25. Nordic Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 26. Rest of Europe Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 27. Asia-Pacific Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 28. China Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 29. Japan Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 30. South Korea Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 31. Southeast Asia Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 32. India Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 33. Australia Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 34. Rest of Asia-Pacific Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 35. Latin America Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 36. Mexico Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 37. Brazil Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 38. Middle East & Africa Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 39. Turkey Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 40. Saudi Arabia Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 41. UAE Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 42. Rest of Middle East & Africa Breast Cancer Diagnostic Market Size YoY Growth (2015-2026) & (US$ Million) Figure 43. Danaher Revenue Growth Rate in Breast Cancer Diagnostic Business (2015-2020) Figure 44. Hologic Revenue Growth Rate in Breast Cancer Diagnostic Business (2015-2020) Figure 45. Merit Medical Revenue Growth Rate in Breast Cancer Diagnostic Business (2015-2020) Figure 46. BD Revenue Growth Rate in Breast Cancer Diagnostic Business (2015-2020) Figure 47. Stryker Revenue Growth Rate in Breast Cancer Diagnostic Business (2015-2020) Figure 48. Galini SRL Revenue Growth Rate in Breast Cancer Diagnostic Business (2015-2020) Figure 49. Medtronic Revenue Growth Rate in Breast Cancer Diagnostic Business (2015-2020) Figure 50. Bottom-up and Top-down Approaches for This Report Figure 51. Data Triangulation Figure 52. Key Executives Interviewed

Danaher Hologic Merit Medical BD Stryker Galini SRL Medtronic